Royalty Pharma Raises $2.2 billion in Biggest IPO of the Year so Far
NEW YORK, June 15, 2020 — Royalty Pharma plc today announced the pricing of the initial public offering of 77,681,670 shares of its Class A ordinary shares pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (“SEC”) at a price to the public of $28.00 per share. The […]